Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3237)
All Articles published online
|
Mar 14, 2012 (publication date) through May 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Park LC, Lee HS, Shin SH, Park SJ, Park MI, Oh SY, Kwon HC, Baek JH, Choi YJ, Kang MJ, Kim YS. Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer. World J Gastroenterol 2012; 18(10): 1104-1109 [PMID: 22416186 DOI: 10.3748/wjg.v18.i10.1104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i10/1104.htm |
| Number | Citing Articles |
| 1 |
Li-Ming Zhu, Ya-Zhen Zhao, Hai-Xing Ju, Lu-Ying Liu, Lei Chen, Bi-Xia Liu, Qi Xu, Cong Luo, Jie-Er Ying, Yun-Shan Yang, Hai-Jun Zhong. Efficacy and Safety of Bevacizumab in Chinese Patients with Metastatic Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 2014; 15(16): 6559 doi: 10.7314/APJCP.2014.15.16.6559
|
| 2 |
Kazuhisa Yamaguchi, Hiroya Taniguchi, Azusa Komori, Yukiya Narita, Sohei Nitta, Motoo Nomura, Shigenori Kadowaki, Daisuke Takahari, Takashi Ura, Masashi Andoh, Kei Muro, Keita Mori, Yoshinori Igarashi. A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1606-1
|
| 3 |
D. Arnold, G.W. Prager, A. Quintela, A. Stein, S. Moreno Vera, N. Mounedji, J. Taieb. Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review. Annals of Oncology 2018; 29(4): 835 doi: 10.1093/annonc/mdy038
|